To explore the biomarkers of venous thromboembolism based on multi-omics technology

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300071641

Enrollment

Unknown

Registered

2023-05-20

Start date

2023-05-20

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism

Interventions

Experimental group:Enrollment was continuous without intervention

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years old; 2. Patients with clinically diagnosed VTE; 3. Voluntarily participate in the clinical trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) History of autoimmune and metabolic diseases; (2) HIV and syphilis positive; (3) cardiovascular events (acute coronary syndrome, cerebrovascular event, myocardial infarction (<3 months), heart failure (EF < 30%, or admission for heart failure within 6 months); (4) unable or unwilling to provide informed consent or to comply with the requirements of the study; (5) History of organ transplantation or serious disease, or other reasons considered by the investigator to be unsuitable for this project.

Design outcomes

Primary

Measure	Time frame
Metagenomics;	—

Secondary

Measure	Time frame
metabonomics;	—

Countries

China

Contacts

Public ContactDengliming

The Second Affiliated Hospital of South China University

deng.liming@usc.edu.cn+86 137 2382 5655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026